List of Tables
Table 1. Global Acute Migraine Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Triptans
Table 3. Major Manufacturers of NSAIDs
Table 4. Major Manufacturers of Others
Table 5. Global Acute Migraine Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Acute Migraine Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Acute Migraine Drugs Sales by Region (2017-2022) & (K Unit)
Table 8. Global Acute Migraine Drugs Sales Forecast by Region (2023-2028) & (K Unit)
Table 9. Global Acute Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Acute Migraine Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Acute Migraine Drugs Sales by Manufacturer (2017-2022) & (K Unit)
Table 12. Global Acute Migraine Drugs Sales Share by Manufacturer (2017-2022)
Table 13. Acute Migraine Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Acute Migraine Drugs Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Acute Migraine Drugs Price (2017-2022) & (USD/Unit)
Table 16. Ranking of Global Top Acute Migraine Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2021)
Table 19. Acute Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Acute Migraine Drugs Product Type
Table 21. Date of International Manufacturers Enter into Acute Migraine Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. GSK Corporation Information
Table 24. GSK Description and Business Overview
Table 25. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 26. GSK Acute Migraine Drugs Product
Table 27. GSK Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 28. GSK Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 29. GSK Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 30. GSK Recent Development
Table 31. Teva Corporation Information
Table 32. Teva Description and Business Overview
Table 33. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 34. Teva Acute Migraine Drugs Product
Table 35. Teva Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 36. Teva Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 37. Teva Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 38. Teva Recent Development
Table 39. Pfizer Corporation Information
Table 40. Pfizer Description and Business Overview
Table 41. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 42. Pfizer Acute Migraine Drugs Product
Table 43. Pfizer Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 44. Pfizer Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 45. Pfizer Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 46. Pfizer Recent Development
Table 47. Novartis Corporation Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Novartis Acute Migraine Drugs Product
Table 51. Novartis Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 52. Novartis Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 53. Novartis Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 54. Novartis Recent Development
Table 55. Sun Pharma Corporation Information
Table 56. Sun Pharma Description and Business Overview
Table 57. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 58. Sun Pharma Acute Migraine Drugs Product
Table 59. Sun Pharma Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 60. Sun Pharma Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 61. Sun Pharma Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 62. Sun Pharma Recent Development
Table 63. Grunenthal Corporation Information
Table 64. Grunenthal Description and Business Overview
Table 65. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 66. Grunenthal Acute Migraine Drugs Product
Table 67. Grunenthal Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 68. Grunenthal Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 69. Grunenthal Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 70. Endo Pharmaceuticals Corporation Information
Table 71. Endo Pharmaceuticals Description and Business Overview
Table 72. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 73. Endo Pharmaceuticals Acute Migraine Drugs Product
Table 74. Endo Pharmaceuticals Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 75. Endo Pharmaceuticals Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 76. Endo Pharmaceuticals Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 77. Merck Corporation Information
Table 78. Merck Description and Business Overview
Table 79. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Merck Acute Migraine Drugs Product
Table 81. Merck Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 82. Merck Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 83. Merck Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 84. J & J Corporation Information
Table 85. J & J Description and Business Overview
Table 86. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. J & J Acute Migraine Drugs Product
Table 88. J & J Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
Table 89. J & J Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
Table 90. J & J Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
Table 91. Global Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
Table 92. Global Acute Migraine Drugs Sales Forecast by Type (2023-2028) & (K Unit)
Table 93. Global Acute Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 94. Global Acute Migraine Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
Table 96. Global Acute Migraine Drugs Sales Forecast by Application (2023-2028) & (K Unit)
Table 97. Global Acute Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 98. Global Acute Migraine Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. North America Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
Table 100. North America Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
Table 101. North America Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 102. North America Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 103. North America Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
Table 104. North America Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
Table 105. Asia-Pacific Acute Migraine Drugs Sales by Region (2017-2022) & (K Unit)
Table 106. Asia-Pacific Acute Migraine Drugs Sales by Region (2023-2028) & (K Unit)
Table 107. Asia-Pacific Acute Migraine Drugs Revenue by Region (2017-2028) & (US$ Million)
Table 108. Asia-Pacific Acute Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 109. Asia-Pacific Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
Table 110. Asia-Pacific Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
Table 111. Europe Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
Table 112. Europe Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
Table 113. Europe Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 114. Europe Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 115. Europe Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
Table 116. Europe Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
Table 117. Latin America Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
Table 118. Latin America Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
Table 119. Latin America Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 120. Latin America Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 121. Latin America Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
Table 122. Latin America Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
Table 123. Middle East and Africa Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
Table 124. Middle East and Africa Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
Table 125. Middle East and Africa Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
Table 128. Middle East and Africa Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
Table 129. Acute Migraine Drugs Key Raw Materials, Industry Status and Trend
Table 130. Acute Migraine Drugs Key Raw Materials and Upstream Suppliers
Table 131. Acute Migraine Drugs Clients Status and Trend
Table 132. Acute Migraine Drugs Typical Clients
Table 133. Acute Migraine Drugs Distributors
Table 134. Acute Migraine Drugs Market Trends
Table 135. Acute Migraine Drugs Market Drivers
Table 136. Acute Migraine Drugs Market Challenges
Table 137. Acute Migraine Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Migraine Drugs Product Picture
Figure 2. Global Acute Migraine Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Triptans Product Picture
Figure 4. NSAIDs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Acute Migraine Drugs Sales Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacies Examples
Figure 8. Drug Stores Examples
Figure 9. Acute Migraine Drugs Report Years Considered
Figure 10. Global Acute Migraine Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Acute Migraine Drugs Market Size 2017-2028 (US$ Million)
Figure 12. Global Acute Migraine Drugs Sales 2017-2028 (K Unit)
Figure 13. Global Acute Migraine Drugs Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Acute Migraine Drugs Revenue Market Share by Region (2017-2028)
Figure 16. Global Acute Migraine Drugs Sales Share by Manufacturer in 2021
Figure 17. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Acute Migraine Drugs Sales Market Share Forecast by Type (2017-2028)
Figure 19. Global Acute Migraine Drugs Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Acute Migraine Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 21. Global Acute Migraine Drugs Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Acute Migraine Drugs Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Acute Migraine Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 24. North America Acute Migraine Drugs Revenue 2017-2028 (US$ Million)
Figure 25. North America Acute Migraine Drugs Sales Market Share by Type (2017-2022)
Figure 26. North America Acute Migraine Drugs Sales Market Share by Application (2017-2022)
Figure 27. Asia-Pacific Acute Migraine Drugs Revenue 2017-2028 (US$ Million)
Figure 28. Asia-Pacific Acute Migraine Drugs Sales Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Acute Migraine Drugs Revenue Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Acute Migraine Drugs Sales Market Share by Type (2017-2022)
Figure 31. Asia-Pacific Acute Migraine Drugs Sales Market Share by Application (2017-2022)
Figure 32. Europe Acute Migraine Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Europe Acute Migraine Drugs Sales Market Share by Country (2017-2028)
Figure 34. Europe Acute Migraine Drugs Revenue Market Share by Country (2017-2028)
Figure 35. Europe Acute Migraine Drugs Sales Market Share by Type (2017-2022)
Figure 36. Europe Acute Migraine Drugs Sales Market Share by Application (2017-2022)
Figure 37. Latin America Acute Migraine Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Latin America Acute Migraine Drugs Sales Market Share by Country (2017-2028)
Figure 39. Latin America Acute Migraine Drugs Revenue Market Share by Country (2017-2022)
Figure 40. Latin America Acute Migraine Drugs Sales Market Share by Type (2017-2022)
Figure 41. Latin America Acute Migraine Drugs Sales Market Share by Application (2017-2022)
Figure 42. Middle East and Africa Acute Migraine Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 43. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Acute Migraine Drugs Sales Market Share by Type (2017-2022)
Figure 46. Middle East and Africa Acute Migraine Drugs Sales Market Share by Application (2017-2022)
Figure 47. Acute Migraine Drugs Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Acute Migraine Drugs Raw Materials by Region in 2021
Figure 49. Acute Migraine Drugs Distribution Channels
Figure 50. Global Acute Migraine Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 51. Global Acute Migraine Drugs Percentage 2017-2028: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation